Umbilical Cord Mesenchymal Stem Cell Therapy for Heart Attacks
Tahapan Penelitian : Recruit
Sponsor:
PT. Prodia StemCell Indonesia
Mitra Pelaksana:
Not Specified
No Registry
INA-84N5CF87
Tanggal Input Registry : 31-01-2025
| Tracking Information | |
|---|---|
| Tanggal Antisipasi Studi | 29-10-2024 |
| Outcome Primer | infarct size |
| Outcome Skunder | major adverse cardiac events |
| Descriptive Information | |
| Judul Penelitian Popular | Umbilical Cord Mesenchymal Stem Cell Therapy for Heart Attacks |
| Judul Penelitian Ilmiah | Role of Umbilical Cord Mesenchymal Stem Cell Therapy in Reducing Infarct Size in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention Primary: A Study of IL-10, VEGF, Galectin 3, Gata-4 and Beclin-1 |
| Jenis Penelitian | Interventional |
| Intervensi | PCI + Umbilical cord mesenchymal stem cell, PCI |
| Jumlah Subyek Penelitian | 60 |
| Recruitment Information | |
| Eligibility Criteria | Inclusion Criteria: Patients aged 30-70 years, Patients experiencing STEMI who undergo Primary PCI within a maximum of 12 hours after the onset of chest pain, Patients willing to participate in the study and complete the informed consent form.Exclusion Criteria: Patients with a history of coronary artery bypass surgery, Patients with a history of cardiac arrest before hospital admission, Patients with cardiogenic shock, Patients with malignant arrhythmia. Patients with malignancy, Patients with chronic kidney disease, Patients with chronic liver disease. Patients with hemostasis disorders, Patients with infections, Patients with a history of stroke. |
| Administrative Information | |
| Nomor Persetujuan Etik | KET-302/UN2.F1/ETIK/PPM.00.02/2023 |
| Nomor Persetujuan Material Transfer Agreement | MTA number |
| Nomor Persetujuan Pelaksanaan Uji Klinik | Not applicable |
| Other Study ID Numbers | |
| Contact Person | Rima Haifa, S.Si, M. Farm-Klin |